- Emmaus Life Sciences press release (OTCQX:EMMA): FY GAAP EPS of -$0.07.
- Revenue of $29.6M (+61.0% Y/Y).
- At December 31, 2023, the company had cash and cash equivalents of $2.5 million, compared with $2.0 million on December 31, 2022.
Emmaus Life Sciences GAAP EPS of -$0.07, revenue of $29.6M
Recommended For You
More Trending News
About EMMA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| EMMA | - | - |
| Emmaus Life Sciences, Inc. | ||